GSK-LSD1 dihydrochloride

CAS No. 1431368-48-7

GSK-LSD1 dihydrochloride( —— )

Catalog No. M17295 CAS No. 1431368-48-7

GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 62 In Stock
10MG 89 In Stock
25MG 148 In Stock
50MG 213 In Stock
100MG 319 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-LSD1 dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
  • Description
    GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    LSD1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1431368-48-7
  • Formula Weight
    289.24
  • Molecular Formula
    C14H22Cl2N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c1ccc(cc1)[C@@H]1C[C@H]1NC1CCNCC1.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Structural Genomics Consortium.
molnova catalog
related products
  • EGFR Inhibitor

    EGFR inhibitor is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.

  • Cavutilide

    Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.

  • Afatinib dimaleate

    An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.